Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Clinical correlates of HIV-1 DNA and inducible HIV-1 RNA reservoirs in peripheral blood in children with perinatally acquired HIV-1 infection with sustained virologic suppression for at least 5 years.

Bitnun A, Ransy DG, Brophy J, Kakkar F, Hawkes M, Samson L, Annabi B, Pagliuzza A, Morand JA, Sauve L, Chomont N, Lavoie S, Kim J, Sandstrom P, Wender P, Lee T, Singer J, Read SE, Soudeyns H; EPIC Research Group.

Clin Infect Dis. 2019 Mar 28. pii: ciz251. doi: 10.1093/cid/ciz251. [Epub ahead of print]

PMID:
30919879
2.

Brief Report: Higher Levels of Angiopoietin-1 Are Associated With Early and Sustained Viral Suppression in Children Living With Vertically Acquired HIV.

Gulhati V, Soo J, Ransy DG, Brophy J, Kakkar F, Bitnun A, Samson L, Read S, Soudeyns H, Hawkes MT; for EPIC4 Study Group.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):590-595. doi: 10.1097/QAI.0000000000001955.

PMID:
30865052
3.

Quasispecies Diversity Is a Major Risk Factor for Vertical Hepatitis C Virus Transmission.

Larouche A, Milton McSween KA, Calderon V, Fauteux-Daniel S, Boulais J, Ransy DG, Boucher M, Lamarre V, Lapointe N, Boucoiran I, Money DM, Krajden M, Le Campion A, Soudeyns H.

J Infect Dis. 2019 Feb 15;219(5):760-771. doi: 10.1093/infdis/jiy581.

PMID:
30365007
4.

Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay.

Châtel L, Yang X, Cholette F, Soudeyns H, Sandstrom P, Lavigne C.

Arch Virol. 2018 Oct;163(10):2701-2710. doi: 10.1007/s00705-018-3894-7. Epub 2018 Jun 7.

PMID:
29882046
5.

Subtle differences in selective pressures applied on the envelope gene of HIV-1 in pregnant versus non-pregnant women.

Ransy DG, Lord E, Caty M, Lapointe N, Boucher M, Diallo AB, Soudeyns H.

Infect Genet Evol. 2018 Aug;62:141-150. doi: 10.1016/j.meegid.2018.04.020. Epub 2018 Apr 17.

PMID:
29678797
6.

Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.

Ajaykumar A, Soudeyns H, Kakkar F, Brophy J, Bitnun A, Alimenti A, Albert AYK, Money DM, Côté HCF; CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children; CIHR Team in Cellular Aging and HIV Comorbidities in Women and Children.

J Infect Dis. 2018 Feb 14;217(5):710-720. doi: 10.1093/infdis/jix618.

7.

Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection.

Fauteux-Daniel S, Larouche A, Calderon V, Boulais J, Béland C, Ransy DG, Boucher M, Lamarre V, Lapointe N, Boucoiran I, Le Campion A, Soudeyns H.

J Virol. 2017 Nov 14;91(23). pii: e01372-17. doi: 10.1128/JVI.01372-17. Print 2017 Dec 1.

8.

Tribute to Mark Wainberg.

Arts EJ, Gatignol A, Mouland AJ, Liang C, Götte M, Soudeyns H.

Retrovirology. 2017 Jun 28;14(1):38. doi: 10.1186/s12977-017-0361-6. No abstract available.

9.

Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.

Calzas C, Taillardet M, Fourati IS, Roy D, Gottschalk M, Soudeyns H, Defrance T, Segura M.

Pathogens. 2017 Apr 20;6(2). pii: E16. doi: 10.3390/pathogens6020016.

10.

Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance.

Abdel-Hakeem MS, Boisvert M, Bruneau J, Soudeyns H, Shoukry NH.

PLoS Pathog. 2017 Feb 1;13(2):e1006191. doi: 10.1371/journal.ppat.1006191. eCollection 2017 Feb.

11.

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.

Wacleche VS, Goulet JP, Gosselin A, Monteiro P, Soudeyns H, Fromentin R, Jenabian MA, Vartanian S, Deeks SG, Chomont N, Routy JP, Ancuta P.

Retrovirology. 2016 Aug 24;13(1):59. doi: 10.1186/s12977-016-0293-6.

12.

Health outcomes and the transition experience of HIV-infected adolescents after transfer to adult care in Québec, Canada.

Kakkar F, Van der Linden D, Valois S, Maurice F, Onnorouille M, Lapointe N, Soudeyns H, Lamarre V.

BMC Pediatr. 2016 Jul 26;16:109. doi: 10.1186/s12887-016-0644-4.

13.

Understanding risk factors for incident maternal HIV-1 infection.

Soudeyns H.

AIDS. 2015 Sep 24;29(15):2053-4. doi: 10.1097/QAD.0000000000000803. No abstract available.

PMID:
26352881
14.

Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

Kakkar F, Boucoiran I, Lamarre V, Ducruet T, Amre D, Soudeyns H, Lapointe N, Boucher M.

J Int AIDS Soc. 2015 Jun 5;18:19933. doi: 10.7448/IAS.18.1.19933. eCollection 2015.

15.

Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Salem Fourati I, Grenier AJ, Jolette É, Merindol N, Ovetchkine P, Soudeyns H.

J Vis Exp. 2014 Jul 9;(89). doi: 10.3791/51643.

16.

Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.

Bitnun A, Samson L, Chun TW, Kakkar F, Brophy J, Murray D, Justement S, Soudeyns H, Ostrowski M, Mujib S, Harrigan PR, Kim J, Sandstrom P, Read SE.

Clin Infect Dis. 2014 Oct;59(7):1012-9. doi: 10.1093/cid/ciu432. Epub 2014 Jun 9.

17.

Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.

Kakkar F, Lamarre V, Ducruet T, Boucher M, Valois S, Soudeyns H, Lapointe N.

BMC Infect Dis. 2014 May 5;14:236. doi: 10.1186/1471-2334-14-236.

18.

Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy.

Zanet DL, Thorne A, Singer J, Maan EJ, Sattha B, Le Campion A, Soudeyns H, Pick N, Murray M, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA.

Clin Infect Dis. 2014 May;58(9):1322-32. doi: 10.1093/cid/ciu051. Epub 2014 Jan 22.

PMID:
24457340
19.

The Young and the Resistant: HIV-Infected Adolescents at the Time of Transfer to Adult Care.

Van der Linden D, Lapointe N, Kakkar F, Ransy DG, Motorina A, Maurice F, Soudeyns H, Lamarre V.

J Pediatric Infect Dis Soc. 2013 Dec;2(4):382-5. doi: 10.1093/jpids/pis106. Epub 2012 Dec 19.

PMID:
26619501
20.

Rejection of leukemic cells requires antigen-specific T cells with high functional avidity.

Vincent K, Hardy MP, Trofimov A, Laumont CM, Sriranganadane D, Hadj-Mimoune S, Salem Fourati I, Soudeyns H, Thibault P, Perreault C.

Biol Blood Marrow Transplant. 2014 Jan;20(1):37-45. doi: 10.1016/j.bbmt.2013.10.020. Epub 2013 Oct 23.

21.

Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Escobar-Gutiérrez A, Soudeyns H, Larouche A, Carpio-Pedroza JC, Martinez-Guarneros A, Vazquez-Chacon CA, Fonseca-Coronado S, Yamasaki LH, Ruiz-Tovar K, Cruz-Rivera M.

Infect Genet Evol. 2013 Dec;20:465-70. doi: 10.1016/j.meegid.2013.10.005. Epub 2013 Oct 18.

22.

Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Ransy DG, Motorina A, Merindol N, Akouamba BS, Samson J, Lie Y, Napolitano LA, Lapointe N, Boucher M, Soudeyns H.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):312-24. doi: 10.1089/AID.2013.0155. Epub 2013 Oct 25. Erratum in: AIDS Res Hum Retroviruses. 2014 May;30(5):509.

23.

Pathogenesis of hepatitis C during pregnancy and childhood.

Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H.

Viruses. 2012 Dec 6;4(12):3531-50. doi: 10.3390/v4123531. Review.

24.

Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation.

Merindol N, Salem Fourati I, Brito RM, Grenier AJ, Charrier E, Cordeiro P, Caty M, Mezziani S, Malette B, Duval M, Alfieri C, Ovetchkine P, Le Deist F, Soudeyns H.

J Immunol. 2012 Nov 15;189(10):5016-28. doi: 10.4049/jimmunol.1201759. Epub 2012 Oct 3.

25.

Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: shorter telomeres with uncontrolled HIV viremia.

Côté HC, Soudeyns H, Thorne A, Alimenti A, Lamarre V, Maan EJ, Sattha B, Singer J, Lapointe N, Money DM, Forbes J; CIHR Emerging Team in HIV therapy, aging (CARMA), Wong J, Bitnun A, Samson L, Brophy J, Burdge D, Pick N, van Schalkwyk J, Montaner J, Harris M, Janssen P.

PLoS One. 2012;7(7):e39266. doi: 10.1371/journal.pone.0039266. Epub 2012 Jul 16.

26.

Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.

Imam T, Jitratkosol MH, Soudeyns H, Sattha B, Gadawski I, Maan E, Forbes JC, Alimenti A, Lapointe N, Lamarre V, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):495-502.

PMID:
22580562
27.

Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Larouche A, Gaëtan G, El-Bilali N, Quesnel-Vallières M, Martin SR, Alvarez F, Shoukry NH, Soudeyns H.

J Clin Microbiol. 2012 Jul;50(7):2515-9. doi: 10.1128/JCM.00622-12. Epub 2012 Apr 25.

28.

Structural basis for broad neutralization of hepatitis C virus quasispecies.

Lapierre P, Troesch M, Alvarez F, Soudeyns H.

PLoS One. 2011;6(10):e26981. doi: 10.1371/journal.pone.0026981. Epub 2011 Oct 26.

29.

CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse.

Merindol N, Champagne MA, Duval M, Soudeyns H.

Blood. 2011 Oct 20;118(16):4480-8. doi: 10.1182/blood-2011-04-349241. Epub 2011 Aug 2.

30.

Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation.

Merindol N, Charrier E, Duval M, Soudeyns H.

J Leukoc Biol. 2011 Jul;90(1):49-60. doi: 10.1189/jlb.0111007. Epub 2011 Mar 2. Review.

PMID:
21367975
31.

Novel HIV-1 recombinant forms in antenatal cohort, Montreal, Quebec, Canada.

Quesnel-Vallières M, Kouzayha I, Tran E, Barry I, Lasgi C, Merindol N, Monteil V, Ransy DG, Boucher M, Lapointe N, Soudeyns H.

Emerg Infect Dis. 2011 Feb;17(2):271-4. doi: 10.3201/eid1702.100629.

32.

Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.

Lavoie PM, Huang Q, Jolette E, Whalen M, Nuyt AM, Audibert F, Speert DP, Lacaze-Masmonteil T, Soudeyns H, Kollmann TR.

J Infect Dis. 2010 Dec 1;202(11):1754-63. doi: 10.1086/657143. Epub 2010 Oct 26.

33.

Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells.

Merindol N, Grenier AJ, Caty M, Charrier E, Duval A, Duval M, Champagne MA, Soudeyns H.

J Immunol. 2010 Jul 15;185(2):856-66. doi: 10.4049/jimmunol.0902613. Epub 2010 Jun 11.

34.

Cell-mediated immune responses directed against hepatitis C virus (HCV) alternate reading frame protein (ARFP) are undetectable during acute infection.

Drouin C, Lamarche S, Bruneau J, Soudeyns H, Shoukry NH.

J Clin Virol. 2010 Jan;47(1):102-3. doi: 10.1016/j.jcv.2009.10.016. Epub 2009 Dec 1. No abstract available.

35.

HCV quasispecies evolution during treatment with interferon alfa-2b and ribavirin in two children coinfected with HCV and HIV-1.

Quesnel-Vallières M, Lemay M, Lapointe N, Martin SR, Soudeyns H.

J Clin Virol. 2008 Oct;43(2):236-40. doi: 10.1016/j.jcv.2008.06.019. Epub 2008 Aug 15.

PMID:
18707918
36.

Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children.

Boulassel MR, Samson J, Khammy A, Lapointe N, Soudeyns H, Routy JP.

Viral Immunol. 2007 Dec;20(4):649-56.

PMID:
18158737
37.

[Maternal immunity and mother-to-child transmission of HCV and HIV-1: challenges and recent advances].

Ransy DG, Akouamba BS, Samson J, Lapointe N, Soudeyns H.

Med Sci (Paris). 2007 Nov;23(11):991-6. French.

38.

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

Allan SE, Alstad AN, Merindol N, Crellin NK, Amendola M, Bacchetta R, Naldini L, Roncarolo MG, Soudeyns H, Levings MK.

Mol Ther. 2008 Jan;16(1):194-202. Epub 2007 Nov 6.

39.

Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein.

Troesch M, Meunier I, Lapierre P, Lapointe N, Alvarez F, Boucher M, Soudeyns H.

Virology. 2006 Sep 1;352(2):357-67. Epub 2006 Jun 16.

40.

HIV-1 genetic diversity in antenatal cohort, Canada.

Akouamba BS, Viel J, Charest H, Merindol N, Samson J, Lapointe N, Brenner BG, Lalonde R, Harrigan PR, Boucher M, Soudeyns H.

Emerg Infect Dis. 2005 Aug;11(8):1230-4.

41.

LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?

Marceau G, Lapierre P, Béland K, Soudeyns H, Alvarez F.

Hepatology. 2005 Sep;42(3):675-82.

PMID:
16037945
42.

Coinfection with hepatitis C virus and human immunodeficiency virus 1 in children: pathogenesis and screening.

Martin SR, Lapointe N, Soudeyns H.

Arch Pediatr Adolesc Med. 2005 Jun;159(6):598-9; author reply 599. No abstract available.

PMID:
15939866
43.

Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.

Troesch M, Jalbert E, Canobio S, Boulassel MR, Routy JP, Bernard NF, Bruneau J, Lapointe N, Boucher M, Soudeyns H.

AIDS. 2005 May 20;19(8):775-84.

PMID:
15867491
44.

Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Canobio S, Guilbert CM, Troesch M, Samson J, Lemay M, Pelletier VA, Bernard-Bonnin AC, Kozielski R, Lapointe N, Martin SR, Soudeyns H.

J Clin Microbiol. 2004 Sep;42(9):4365-9.

45.

Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.

Soudeyns H, Campi G, Rizzardi GP, Lenge C, Demarest JF, Tambussi G, Lazzarin A, Kaufmann D, Casorati G, Corey L, Pantaleo G.

Blood. 2000 Mar 1;95(5):1743-51.

47.

Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope.

Soudeyns H, Paolucci S, Chappey C, Daucher MB, Graziosi C, Vaccarezza M, Cohen OJ, Fauci AS, Pantaleo G.

Eur J Immunol. 1999 Nov;29(11):3629-35.

48.

The moving target: mechanisms of HIV persistence during primary infection.

Soudeyns H, Pantaleo G.

Immunol Today. 1999 Oct;20(10):446-50. Review.

PMID:
10500291
49.

Immunopathogenesis of HIV infection.

Graziosi C, Soudeyns H, Rizzardi GP, Bart PA, Chapuis A, Pantaleo G.

AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S135-42. Review. No abstract available.

PMID:
9672230
50.

Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.

Fleury S, de Boer RJ, Rizzardi GP, Wolthers KC, Otto SA, Welbon CC, Graziosi C, Knabenhans C, Soudeyns H, Bart PA, Gallant S, Corpataux JM, Gillet M, Meylan P, Schnyder P, Meuwly JY, Spreen W, Glauser MP, Miedema F, Pantaleo G.

Nat Med. 1998 Jul;4(7):794-801.

PMID:
9662370

Supplemental Content

Loading ...
Support Center